M Robert Leanna

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent. Top assignees: Abbott Laboratories Corporation, Medivir Ab, Eli Lilly and Company. Active years: 1993-2009.

USPTO Granted Patents = 18

% Patents Active = 77.8

CIPO Patents = 1

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 67(Granted Patents)

Location History:

Mundelein, IL (US) (1993 - 1996)
Grayslake, IL (US) (1996 - 2009)

Company Filing History:

11 out of 4,186

Abbott Laboratories Corporation

Eli Lilly and Company

patents

Years Active: 1993-2009

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7538105 - Anti-infective agents (2009-05-26),

2. 7378414 - Anti-infective agents (2008-05-27),

3. 7189849 - Synthesis of acyclic nucleoside derivatives (2007-03-13),

4. 6878844 - Synthesis of acyclic nucleoside derivatives (2005-04-12),

5. 6613936 - Synthesis of acyclic nucleoside derivatives (2003-09-02),

6. 6576763 - Acyclic nucleoside derivatives (2003-06-10),

7. 6184376 - Synthesis of acyclic nucleoside derivatives (2001-02-06),

8. 5712400 - Process for preparation of 5-hydroxymethylthiazole (1998-01-27),

9. 5625092 - Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane (1997-04-29),

10. 5616776 - Process for the preparation of a substituted 2.5-diamono-3-hydroxy-hexane (1997-04-01),

11. 5559245 - Intermediates to 4-amino- hexahydrobenz (cd) indoles and processes (1996-09-24),

12. 5543552 - Process for the prepartation of a substituted 2,5-diamino-3-hydroxyhexane (1996-08-06),

13. 5543551 - Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane (1996-08-06),

14. 5541328 - Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane (1996-07-30),

15. 5491253 - Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane (1996-02-13),

Title: M Robert Leanna: Innovator in Anti-Infective Agents

Introduction

M Robert Leanna is a prominent inventor based in Grayslake, IL (US), known for his significant contributions to the field of anti-infective agents. With a total of 18 patents to his name, he has made remarkable strides in developing compounds that inhibit hepatitis C polymerase.

Latest Patents

His latest patents focus on anti-infective agents, specifically compounds that serve as hepatitis C (HCV) polymerase inhibitors. These patents disclose compositions and methods for inhibiting HCV polymerase, along with processes for making the compounds and the synthetic intermediates employed in these processes.

Career Highlights

Throughout his career, M Robert Leanna has worked with notable companies such as Abbott Laboratories Corporation and Medivir Ab. His work has been instrumental in advancing the understanding and treatment of viral infections.

Collaborations

Some of his notable coworkers include Howard E Morton and Jien-Heh J Tien, who have contributed to his research and development efforts.

Conclusion

M Robert Leanna's innovative work in the field of anti-infective agents has positioned him as a key figure in the fight against hepatitis C. His contributions continue to impact the medical community and advance therapeutic options for patients.